Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities:
Net earnings (losses)	$ (20)	$ 367
Adjustments to reconcile net earnings (losses) to net cash provided by operations:
Depreciation and amortization	174	167
Stock-based compensation	60	44
Deferred income taxes	(122)	11
Goodwill, trademark and other asset impairments	445	0
Other	34	7
Changes in:
Receivables, net	(1)	(56)
Inventories, net	13	(53)
Prepaid expenses and other current assets	(15)	2
Accounts payable and accrued liabilities	78	(93)
Operating lease right-of-use assets and liabilities, net	2	0
Income taxes payable / prepaid	80	55
Net cash provided by operations	728	451
Investing activities:
Capital expenditures	(144)	(172)
Other	2	5
Net cash used for investing activities	(142)	(167)
Financing activities:
Notes and loans payable, net	(99)	395
Long-term debt repayments	0	(300)
Treasury stock purchased	0	(25)
Cash dividends paid to Clorox stockholders	(437)	(428)
Cash dividends paid to noncontrolling interests	0	(5)
Issuance of common stock for employee stock plans and other	10	0
Net cash used for financing activities	(526)	(363)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	0	(2)
Net increase (decrease) in cash, cash equivalents, and restricted cash	60	(81)
Cash, cash equivalents, and restricted cash:
Beginning of period	186	324
End of period	$ 246	$ 243